Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
A GLP-1 receptor agonist delivered directly into the knee joint received FDA Fast Track designation for osteoarthritis with synovitis, with phase 2a data not expected until 2027.
Family Medicine/General Practice May 6th 2026
MDLinx
“At the end of the day, it’s vital to avoid overuse of opioids—when the harms would outweigh the benefits—but also to avoid underuse.” – Cary P. Gross, MD, Professor of Medicine at YSM
Oncology, Medical April 14th 2026
Clinical Advisor
Patient history and self-perception are valuable factors, but should never confirm a diagnosis and must be weighed against objective findings.
Nurse Practitioner (NP) April 13th 2026
MDSpire News
“Basically women were told: ‘You’re lucky to be alive. Some pain is expected. Suck it up and deal with it.'” — Dr. Sean Mackey, Stanford University Pain Medicine
Obstetrics & Gynecology April 8th 2026
Annals of Internal Medicine
The primary end point was the area under the curve (AUC) of the daily worst bone pain score (assessed using the “worst pain” question from the Brief Pain Inventory, a 0 to 10 numerical rating scale [NRS]) for 5 consecutive days in the first chemotherapy cycle.
Hematology/Oncology March 30th 2026
Epoch Health
The FDA notice added that a letter was sent out about the recall. However, it did not include a press release or other specific details.
Emergency Medicine March 26th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS